---
title: "Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293798083.md"
description: "Matinas BioPharma announced the immediate termination of its $50 million At-The-Market (ATM) Sales Agreement with BTIG, effective July 23, 2026. The original agreement, signed in July 2020, allowed the sale of up to $50 million in common stock. BTIG exercised its contractual right to terminate the arrangement without any penalties or fees. This action removes Matinas' current ATM financing option unless a new program is established."
datetime: "2026-07-24T21:03:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293798083.md)
  - [en](https://longbridge.com/en/news/293798083.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293798083.md)
generator: "portal-rs"
---

# Matinas BioPharma $50 Million ATM Program With BTIG Terminated With No Penalties

Matinas BioPharma announced the termination of its At-The-Market Sales Agreement with BTIG, effective immediately on July 23, 2026. The agreement, originally signed on July 2, 2020, allowed the company to sell up to $50 million of common stock through at-the-market offerings. BTIG ended the arrangement under its contractual rights, and no termination fees or expenses are due. The change removes this at-the-market financing option unless Matinas establishes a new program.

**Agreement details:**

-   **Agreement terminated**: At-The-Market Sales Agreement
-   **Counterparty**: BTIG
-   **Original agreement date**: Jul 02 2020
-   **Termination date**: Jul 23 2026
-   **Termination type**: Early
-   **Exit fees / payments**: None
-   **Reason**: BTIG exercised its contractual termination right

Original SEC Filing: Matinas BioPharma Holdings, Inc. \[ MTNB \] - 8-K - Jul. 24, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)

## Related News & Research

- [Matinas BioPharma says warrant exercise brings in about $2.6 million cash proceeds](https://longbridge.com/en/news/292486089.md)
- [BTIG Flags Major Risk for S&P 500](https://longbridge.com/en/news/296391627.md)
- [Diversify Advisory Services LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/296585791.md)
- [BTIG highlights the unusual absence of broad selling pressure in 2026](https://longbridge.com/en/news/296131503.md)
- ["Factor Musical Chairs": We Have Never Seen Such A Decoupling Between Price And Breadth](https://longbridge.com/en/news/296288605.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**